Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia—Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study

Allogeneic hematopoietic cell transplantation (allo-HCT) is the only cure for acute myeloid leukemia (AML) in second complete remission (CR2) Patients lacking a matched sibling donor (MSD) receive transplants from mismatched unrelated donors .

A convolutional neural network‐based, quantitative complete blood count scattergram‐mapping framework promptly screens acute promyelocytic leukemia with high sensitivity

An innovative convolutional neural network-based framework is the first to use scattergram output from routine CBC analysis to map suspicious APL early with outstanding sensitivity, specificity, and precision . The authors recommend using this method even before analyzing cell images, which could provide the earliest way to screen for APL in a sensitive and accurate way… Continue reading A convolutional neural network‐based, quantitative complete blood count scattergram‐mapping framework promptly screens acute promyelocytic leukemia with high sensitivity